UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

European journal of nuclear medicine and molecular imaging, 2022-01, Vol.49 (2), p.721-731

2022

Volltextzugriff (PDF)

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers

European journal of nuclear medicine and molecular imaging, 2020-11, Vol.47 (12), p.2836-2845

2020

Volltextzugriff (PDF)

Effect of obesity and weight loss on ventricular repolarization: a systematic review and meta-analysis

Obesity reviews, 2016-06, Vol.17 (6), p.520-530

2016

Volltextzugriff (PDF)

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

Radiation oncology (London, England), 2022-04, Vol.17 (1), p.75-75, Article 75

2022

Volltextzugriff (PDF)

Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial

Strahlentherapie und Onkologie, 2024-03, Vol.200 (3), p.202-207

2024

Volltextzugriff (PDF)

Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements

Molecular imaging and biology, 2023-04, Vol.25 (2), p.324-333

2023

Volltextzugriff (PDF)

Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?: Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)

Strahlentherapie und Onkologie, 2024-03, Vol.200 (3), p.181-187

2024

Volltextzugriff (PDF)

Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime

World journal of urology, 2017-12, Vol.35 (12), p.1841-1847

2017

Volltextzugriff (PDF)

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma: A dosimetric comparison

Strahlentherapie und Onkologie, 2016-11, Vol.192 (11), p.770-779

2016

Volltextzugriff (PDF)

Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study

Journal of interventional cardiac electrophysiology, 2019-03, Vol.54 (2), p.171-176

2019

Volltextzugriff (PDF)

Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer

Radiation oncology (London, England), 2016-11, Vol.11 (1), p.150-150, Article 150

2016

Volltextzugriff (PDF)

Introduction of a new standardized assessment score of spine morphology in osteogenesis imperfecta

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2012-08, Vol.184 (8), p.719

2012

Volltextzugriff (PDF)

Standardized x-ray reports of the spine in osteogenesis imperfecta

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2011-05, Vol.183 (5), p.462

2011

Volltextzugriff (PDF)

Potent Somatostatin Undecapeptide Agonists Selective for Somatostatin Receptor 1 (sst1)

Journal of medicinal chemistry, 2001-06, Vol.44 (13), p.2238-2246

2001

Volltextzugriff (PDF)

Imaging of oligometastatic disease in selected urologic cancers

Urologe. Ausgabe A, 2021-12, Vol.60 (12), p.1561

2021

Volltextzugriff (PDF)

Management of bleeding in patients receiving non-vitamin K antagonists

Postgraduate Medical Journal, 2017-04, Vol.93 (1098), p.221-225

2017

Volltextzugriff (PDF)

Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor

The Journal of biological chemistry, 2001-08, Vol.276 (34), p.31528-31534

2001

Volltextzugriff (PDF)

Constrained Corticotropin-Releasing Factor Antagonists with i-(i + 3) Glu−Lys Bridges

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3651-3658

1997

Volltextzugriff (PDF)

Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i−(i+3) Glu-Xaa-dXbb-Lys Bridges

Journal of medicinal chemistry, 1998-12, Vol.41 (25), p.5002-5011

1998

Volltextzugriff (PDF)

Design of Monocyclic (1−3) and Dicyclic (1−3/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.797-806

2000

Volltextzugriff (PDF)

Design of Potent Dicyclic (4−10/5−8) Gonadotropin Releasing Hormone (GnRH) Antagonists

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.784-796

2000

Volltextzugriff (PDF)

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

Radiation oncology (London, England), 2022-03, Vol.17 (1), p.59-59, Article 59

2022

Volltextzugriff (PDF)

Conformationally Restricted Competitive Antagonists of Human/Rat Corticotropin-Releasing Factor

Journal of medicinal chemistry, 1994-05, Vol.37 (10), p.1450-1459

1994

Volltextzugriff (PDF)

Design of Potent Dicyclic (1−5/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.807-818

2000

Volltextzugriff (PDF)

Human Growth Hormone-Releasing Hormone hGHRH(1−29)-NH2: Systematic Structure−Activity Relationship Studies

Journal of medicinal chemistry, 1998-02, Vol.41 (5), p.717-727

1998

Volltextzugriff (PDF)

1 – 25 von 546

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(495)
Mit Volltextzugriff
(414)

Publikationsform

Artikel
(544)
magazinearticle
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(472)
Life Sciences & Biomedicine
(455)
Male
(264)
Female
(262)
Middle Aged
(140)
Aged
(132)
Adult
(126)
Retrospective Studies
(70)
Treatment Outcome
(70)
Aged, 80 And Over
(68)
Biological And Medical Sciences
(68)
Animals
(65)
Child
(61)
Medical Sciences
(57)
Oncology
(57)
Adolescent
(54)
Dermatology
(52)
Radiology, Nuclear Medicine & Medical Imaging
(51)
Cardiovascular System & Cardiology
(49)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers

Effect of obesity and weight loss on ventricular repolarization: a systematic review and meta-analysis

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial

Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements

Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?: Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)

Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma: A dosimetric comparison

Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study

Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer

Introduction of a new standardized assessment score of spine morphology in osteogenesis imperfecta

Standardized x-ray reports of the spine in osteogenesis imperfecta

Potent Somatostatin Undecapeptide Agonists Selective for Somatostatin Receptor 1 (sst1)

Imaging of oligometastatic disease in selected urologic cancers

Management of bleeding in patients receiving non-vitamin K antagonists

Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor

Constrained Corticotropin-Releasing Factor Antagonists with i-(i + 3) Glu−Lys Bridges

Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i−(i+3) Glu-Xaa-dXbb-Lys Bridges

Design of Monocyclic (1−3) and Dicyclic (1−3/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists

Design of Potent Dicyclic (4−10/5−8) Gonadotropin Releasing Hormone (GnRH) Antagonists

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

Conformationally Restricted Competitive Antagonists of Human/Rat Corticotropin-Releasing Factor

Design of Potent Dicyclic (1−5/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists

Human Growth Hormone-Releasing Hormone hGHRH(1−29)-NH2: Systematic Structure−Activity Relationship Studies

Aktive Filter

Suchergebnisse filtern